Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
When breast cancer spreads around the body, it's called secondary breast cancer. It can be treated, but it currently can't be cured. Our research could help buy more time so people can live their lives to the fullest for as long as possible.
Our research has 1 main goal. To stop secondary breast cancer in its tracks.
It covers many different areas. From improving our understanding of secondary breast cancer and developing better treatments. To improving the care and support services for people living with it.
Right now, some of the brightest minds in breast cancer research are making progress in every aspect of secondary breast cancer.
We estimate that around 61,000 people are living with incurable secondary breast cancer in the UK. And in around 5% of women, breast cancer has already spread by the time it's diagnosed.
Right now, we’re funding £5.3 million worth of research into secondary breast cancer. And we hope breakthroughs from our research into other areas of breast cancer will also benefit people with secondary breast cancer in the future.
Breast cancer is affecting more of us than ever before. And each month in the UK, around 1,000 people die from secondary breast cancer. That’s someone dying every 45 minutes.
For decades, scientists have been trying to understand why breast cancer spreads around the body. For people living with secondary breast cancer, it could be life-changing. We need to understand the disease better to give them and their loved ones more time. We need to treat it better. We need research. That's why we’re investing in groundbreaking science.
If there was more research around secondary breast cancer, more of us could probably live for a lot longer.
Emma, living with secondary breast cancer
Professor Penelope Ottewell is testing new combinations of drugs to treat breast cancer that’s spread to the bone. She hopes this work could eventually lead to new treatments for people with secondary breast cancer.
Dr Damir Varešlija is looking at how gene switches in breast cancer cells might make them more likely to spread to the brain. He hopes to find ways to stop this from happening.